Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARAY · against 25 other Healthcare companies of similar size
Ranked #26 of 26 · scores higher than 0% of peers · safety percentile 3
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)4 peers with a safety percentile of 0–9, including ARAY · Click a bar to see the companies
Mainly because of its debt / equity, beta and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ARAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 21 reported | 4.41× | 0.18× | 0% | 33% | |
| BetaLower is better · 25 reported | 1.42 | 0.64 | 25% | 33% | |
| Current ratioHigher is better · 26 reported | 1.50× | 2.58× | 32% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 276M SEK (≈$28M) | 96 | 48 | |
| 2 | 31M USD | 91 | ||
| 3 | 298M SEK (≈$30M) | 83 | 48 | |
| 4 | 22M USD | 81 | 47 | |
| 5 | 2.8B JPY (≈$19M) | 78 | ||
| 22 | 18M AUD (≈$12M) | 13 | 7 | |
| 23 | 390.5B IDR (≈$24M) | 9 | 8 | |
| 24 | 3.4B JPY (≈$23M) | 7 | 5 | |
| 25 | 17M USD | 6 | 10 | |
| 26 | 17M USD | 3 | 16 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score